These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 35500745)
1. PRMT5 determines the pattern of polyploidization and prevents liver from cirrhosis and carcinogenesis. Wang J; Huang X; Zheng D; Li Q; Mei M; Bao S J Genet Genomics; 2023 Feb; 50(2):87-98. PubMed ID: 35500745 [TBL] [Abstract][Full Text] [Related]
2. OGG1 regulates the level of symmetric dimethylation of histone H4 arginine-3 by interacting with PRMT5. Zhou X; Wang W; Du C; Yan F; Yang S; He K; Wang H; Zhao A Mol Cell Probes; 2018 Apr; 38():19-24. PubMed ID: 29409673 [TBL] [Abstract][Full Text] [Related]
3. PRMT5-mediated histone H4 arginine-3 symmetrical dimethylation marks chromatin at G + C-rich regions of the mouse genome. Girardot M; Hirasawa R; Kacem S; Fritsch L; Pontis J; Kota SK; Filipponi D; Fabbrizio E; Sardet C; Lohmann F; Kadam S; Ait-Si-Ali S; Feil R Nucleic Acids Res; 2014 Jan; 42(1):235-48. PubMed ID: 24097435 [TBL] [Abstract][Full Text] [Related]
4. Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α. Zheng BN; Ding CH; Chen SJ; Zhu K; Shao J; Feng J; Xu WP; Cai LY; Zhu CP; Duan W; Ding J; Zhang X; Luo C; Xie WF Theranostics; 2019; 9(9):2606-2617. PubMed ID: 31131056 [No Abstract] [Full Text] [Related]
5. Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin. Zhang B; Dong S; Li Z; Lu L; Zhang S; Chen X; Cen X; Wu Y J Transl Med; 2015 Nov; 13():349. PubMed ID: 26541651 [TBL] [Abstract][Full Text] [Related]
6. Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma. Luo Y; Gao Y; Liu W; Yang Y; Jiang J; Wang Y; Tang W; Yang S; Sun L; Cai J; Guo X; Takahashi S; Krausz KW; Qu A; Chen L; Xie C; Gonzalez FJ Hepatology; 2021 Oct; 74(4):1932-1951. PubMed ID: 33896016 [TBL] [Abstract][Full Text] [Related]
7. Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin. Cai S; Wang P; Xie T; Li Z; Li J; Lan R; Ding Y; Lu J; Ye J; Wang J; Li Z; Liu P Pharmacol Res; 2020 Nov; 161():105104. PubMed ID: 32739429 [TBL] [Abstract][Full Text] [Related]
8. Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5. Fulton MD; Dang T; Brown T; Zheng YG Epigenetics; 2022 Jan; 17(1):1-18. PubMed ID: 33380261 [TBL] [Abstract][Full Text] [Related]
9. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD). Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346 [TBL] [Abstract][Full Text] [Related]
10. Histone arginine methylation by Prmt5 is required for lung branching morphogenesis through repression of BMP signaling. Li Q; Jiao J; Li H; Wan H; Zheng C; Cai J; Bao S J Cell Sci; 2018 Jul; 131(14):. PubMed ID: 29950483 [TBL] [Abstract][Full Text] [Related]
11. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression. Chen H; Lorton B; Gupta V; Shechter D Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440 [TBL] [Abstract][Full Text] [Related]
12. PHD finger protein 1 (PHF1) is a novel reader for histone H4R3 symmetric dimethylation and coordinates with PRMT5-WDR77/CRL4B complex to promote tumorigenesis. Liu R; Gao J; Yang Y; Qiu R; Zheng Y; Huang W; Zeng Y; Hou Y; Wang S; Leng S; Feng D; Yu W; Sun G; Shi H; Teng X; Wang Y Nucleic Acids Res; 2018 Jul; 46(13):6608-6626. PubMed ID: 29846670 [TBL] [Abstract][Full Text] [Related]
13. Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells. Mongiardi MP; Savino M; Bartoli L; Beji S; Nanni S; Scagnoli F; Falchetti ML; Favia A; Farsetti A; Levi A; Nasi S; Illi B Sci Rep; 2015 Nov; 5():15494. PubMed ID: 26563484 [TBL] [Abstract][Full Text] [Related]
14. KSHV encoded ORF59 modulates histone arginine methylation of the viral genome to promote viral reactivation. Strahan RC; McDowell-Sargent M; Uppal T; Purushothaman P; Verma SC PLoS Pathog; 2017 Jul; 13(7):e1006482. PubMed ID: 28678843 [TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein promotes PRMT5-mediated H4R3me2s histone methylation by interacting with the BAF complex. Nakamura T; Sugeno N; Hasegawa T; Ikeda K; Yoshida S; Ishiyama S; Sato K; Takeda A; Aoki M FEBS J; 2024 May; 291(9):1892-1908. PubMed ID: 38105619 [TBL] [Abstract][Full Text] [Related]
16. Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation. Ge S; Zhang Q; Chen Y; Tian Y; Yang R; Chen X; Li F; Zhang B Toxicol Appl Pharmacol; 2021 Mar; 415():115450. PubMed ID: 33577917 [TBL] [Abstract][Full Text] [Related]
17. Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. Ancelin K; Lange UC; Hajkova P; Schneider R; Bannister AJ; Kouzarides T; Surani MA Nat Cell Biol; 2006 Jun; 8(6):623-30. PubMed ID: 16699504 [TBL] [Abstract][Full Text] [Related]
18. PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression. Liu M; Yao B; Gui T; Guo C; Wu X; Li J; Ma L; Deng Y; Xu P; Wang Y; Yang D; Li Q; Zeng X; Li X; Hu R; Ge J; Yu Z; Chen Y; Chen B; Ju J; Zhao Q Theranostics; 2020; 10(10):4437-4452. PubMed ID: 32292506 [TBL] [Abstract][Full Text] [Related]
19. Histone H2A and H4 N-terminal tails are positioned by the MEP50 WD repeat protein for efficient methylation by the PRMT5 arginine methyltransferase. Burgos ES; Wilczek C; Onikubo T; Bonanno JB; Jansong J; Reimer U; Shechter D J Biol Chem; 2015 Apr; 290(15):9674-89. PubMed ID: 25713080 [TBL] [Abstract][Full Text] [Related]
20. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3. Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]